Table 1.
Group | N | SNHG1 expression | χ2 | p value | ||
---|---|---|---|---|---|---|
low | high | |||||
Type | Normal | 14 | 14 | 0 | 21.157 | <0.001 |
Adenocarcinoma | 67 | 22 | 45 | |||
Age | ≤ 65 | 26 | 8 | 18 | 0.082 | 0.774 |
> 65 | 41 | 14 | 27 | |||
Clinical stage | I-II | 42 | 15 | 27 | 0.423 | 0.516 |
III-IV | 25 | 7 | 18 | |||
Primary tumor | T1-T2 | 44 | 16 | 28 | 0.723 | 0.395 |
T3-T4 | 23 | 6 | 17 | |||
Gleason score | ≤ 6 | 17 | 9 | 8 | 4.175 | 0.041 |
≥ 7 | 50 | 13 | 37 |
SNHG1 expression was determined by FISH; p value is from χ2-test -test.
A remarkably increasing frequency of positive expression of SNHG1 was detected in prostate cancer specimens compared to normal prostate tissues (P < 0.001, χ2-test).